An Ethical Framework for Thinking about Canine Research and Animal - - PowerPoint PPT Presentation

an ethical framework for
SMART_READER_LITE
LIVE PREVIEW

An Ethical Framework for Thinking about Canine Research and Animal - - PowerPoint PPT Presentation

An Ethical Framework for Thinking about Canine Research and Animal Research More Generally DAVID DEGRAZIA, PH.D. SENIOR RESEARCH FELLOW, DEPARTMENT OF BIOETHICS, NIH ELTON PROFESSOR OF PHILOSOPHY, GWU Disclaimer & Disclosure I speak


slide-1
SLIDE 1

An Ethical Framework for Thinking about Canine Research—and Animal Research More Generally

DAVID DEGRAZIA, PH.D. SENIOR RESEARCH FELLOW, DEPARTMENT OF BIOETHICS, NIH ELTON PROFESSOR OF PHILOSOPHY, GWU

slide-2
SLIDE 2

Disclaimer & Disclosure

I speak today for myself, not for NIH or any other part of the U.S. federal government I have no conflicts of interest

slide-3
SLIDE 3

Plan

Background for the ethical framework Principles of Social Benefit Principles of Animal Welfare A word about the 3 Rs A decision tree for evaluating canine studies Final thoughts

slide-4
SLIDE 4

Background

PART 1

slide-5
SLIDE 5

Our project

Beauchamp & DeGrazia, Principles of Animal Research Ethics (Oxford UP, in production) About my coauthor: coauthor of Principles of Biomedical Ethics Commentaries by

  • Larry Carbone
  • Frans de Waal
  • Rebecca Dresser
  • Joseph Garner
  • Brian Hare
  • Margaret Landi
  • Julian Savulescu
slide-6
SLIDE 6

But why now?

Growing public concerns about animals Advances in scientific study of animal cognition & consciousness Growth of animal ethics as a discipline Increasing concerns among scientists about translation Advances in science of alternatives

slide-7
SLIDE 7

Purpose

Present a framework of general principles for (laboratory) animal research Should be

  • responsive to these recent developments
  • ethically defensible
  • politically reasonable
  • useful to those engaged in review or conduct of animal research
slide-8
SLIDE 8

Challenge

Differences about animals’ moral status & value of animal research

  • Biomedical research community
  • Animal-protection community
slide-9
SLIDE 9

Strategy: work from points of convergence

Claims that open-minded members of both communities can accept:

  • 1. Sentient animals have moral status
  • 2. Any justification for harming (nonconsenting) beings w/moral

status must appeal to substantial social benefits

  • 3. Any permissible harming of animal subjects is limited by

considerations of animal welfare

slide-10
SLIDE 10

Sentience

Sentience = capacity to have (un)pleasant experiences Which animals? Working assumption: vertebrates & cephalopods Includes dogs Works well with current US and EU policy

slide-11
SLIDE 11

Other points of convergence

Any justification of animal research must appeal to:

  • Prospect of substantial social benefits
  • Adequate protection of animal subjects’ welfare

Core values: social benefit & animal welfare Already accepted Yet support principles of a new framework

slide-12
SLIDE 12

Structure of framework

Social Benefit

No Alternative Method Expected Net Benefit Sufficient Value to Justify Harm

Animal Welfare

No Unnecessary Harm Basic Needs Upper Limits to Harm

slide-13
SLIDE 13

Principles of Social Benefit

PART 2

slide-14
SLIDE 14
  • 1. No Alternative Method

The knowledge sought must not be realistically obtainable from alternatives Idea: Beings w/moral status shouldn’t be harmed if benefits are obtainable w/out harming them If principle is met, animal study offers prospect of unique benefit

slide-15
SLIDE 15

What about alternatives?

Where alternatives are adequate, animal studies don’t offer unique benefits The scientific issues are highly complex But alternatives are making progress

slide-16
SLIDE 16

For toxicity testing

  • A. Rowan: EPA’s ToxCast program is comparably accurate to

the best animal tests of chemicals—and much faster & cheaper (“Ending the use of animals in toxicity testing and risk evaluation,” CQHE 24 [2015]: 448-58) Some scientists are impressed by potential of microdosing

(R. D. Combes et al., “Early microdose drug studies in human volunteers can minimise animal testing,” European Journal

  • f Pharmaceutical Sciences 19 [2003]: 1-11)
slide-17
SLIDE 17

Beyond toxicity

Growing interest in naturally occurring diseases in animals, including dogs, as a model (J. Rowell, “Dog models of naturally occurring cancer,” Trends in

Molecular Medicine [17] [2011]: 380-88; G. Ranieri et al., “A Model of Study for Human Cancer: Spontaneous occurring tumors in dogs,” Critical Reviews in Oncology/Hematology 88 [2013]: 187-197)

FDA Commissioner S. Gottlieb about the possibility of eliminating use of dogs in animal drug development: “In our study, no dogs would be euthanized. …[R]esearchers will draw a small amount of blood … at specified intervals…. [W]e expect to be able to use these data to develop informatics tools that can model the absorption of drugs in the future, rather than requiring the drugs to be tested on live dogs” (FDA Statement, November 16, 2018; available at

www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626060.htm)

slide-18
SLIDE 18

More on alternatives

Isn’t No Alternative Method equivalent to “Replacement”? Different force

  • “Methods such as mathematical models, computer simulation, and

in vitro biological systems should be considered” (U.S. Government Principles)

  • Present principle states a requirement
slide-19
SLIDE 19
  • 2. Expected Net Benefit

Some animal studies offer unique benefits All animal research has costs This principle focuses on costs & benefits to humans Requires that prospect of benefit exceed anticipated costs

slide-20
SLIDE 20

Complexity of expected benefit

Expected benefit = (1) amount of benefit (if achieved) x (2) likelihood of achieving it So hoped-for benefit must be multiplied by x < 1 While logically obvious, the probability factor is often

  • verlooked
slide-21
SLIDE 21

RE Benefits: Concerns about translation

Attrition rate from successful animal studies may be 80 or 90% (I.

Kola & J. Landis, “Can the pharmaceutical industry reduce attrition rates?” Nature Reviews 3 [2004]: 711-715; H. B. van der Worp et al., “Can animal models of disease reliably inform human studies?” PLOS Medicine 7 [3] [2010]; S. Perrin, “Make mouse studies work,” Nature 507 [2014]: 423-425); J. Garner, “The significance of meaning: Why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it?” ILAR Journal 55 [2014]: 438-456)

A systematic review: Among highly cited animal studies, about 1/3 translated (D. G. Hackman and D. A. Redelmeier, “Translation of research evidence from animals to humans,”

JAMA 296 [2006]: 1731-1732)

Don’t have data for canine studies in particular

slide-22
SLIDE 22

Costs to consider

Relevant costs in Expected Net Benefit are costs to humans Include financial costs, opportunity costs & risks associated w/imperfect models The less adequate an animal model (for testing), the greater the risk of

  • False toxicity negatives
  • False toxicity positives
  • False efficacy negatives
  • False efficacy positives
slide-23
SLIDE 23

Expected Net Benefit is required for justification even from a human-centered standpoint As a necessary condition, seems self-evident Yet it sets a rigorous standard

slide-24
SLIDE 24
  • 3. Sufficient Value to Justify

Harm

Suppose 1st two principles are met: an animal study (1)

  • ffers a unique benefit and (2) prospect of benefit exceeds

projected costs (to humans) Doesn’t follow that it’s ethical Q: Is the prospect of benefit important enough to justify anticipated harms to canine (or other animal) subjects? Note: We cannot expect full agreement on the answer

slide-25
SLIDE 25

Together, principles of social benefit require prospect of unique, net benefit sufficient to justify anticipated harms to animals Both champions of animal research & animal protectionists can accept this demand Will sometimes disagree on which studies satisfy it

slide-26
SLIDE 26

Principles of Animal Welfare

PART 3

slide-27
SLIDE 27
  • 1. No Unnecessary Harm

Grounded in nonmaleficence States that animal subjects must never be harmed (1) through negligence or (2) intentionally unless such harm is unavoidable given scientific objectives that satisfy principles

  • f social benefit
slide-28
SLIDE 28

Relevant harms not limited to procedures Include conditions of housing, handling, transport, accidental spread of disease, etc.

slide-29
SLIDE 29
  • 2. Basic Needs

Requires meeting animals’ basic needs unless incompatible with scientific objectives Basic needs = what’s ordinarily required for a decent life

slide-30
SLIDE 30

Why do research animals deserve such benefits? Principle justified via special relationship between human personnel & animal subjects Idea: In relationships where some are made totally dependent on others’ continued care, failure to meet basic needs = harm

slide-31
SLIDE 31

List of basic needs

Nutritious food & clean water Appropriate shelter Adequate stimulation, exercise, opportunities for canine- typical functioning Sufficient rest for health Veterinary care

slide-32
SLIDE 32

(cont.)

Access to compatible dogs or social group members Freedom from significant experiential harm Freedom from disease, injury, disability Freedom of movement w/adequate space

slide-33
SLIDE 33

A possible addition to list

Avoidance of premature death? Left open …

slide-34
SLIDE 34
  • 3. Upper Limits to Harm

Principles so far permit harm when necessary for justified scientific objectives Set no limit on permissible harm None exists in U.S. policy Permitted

  • Induced terminal heart attacks in dogs (C. Khalid et al., “Reversal of global apoptosis and

regional stress kinase activation by cardiac resynchronization,” Circulation 117 [2008]: 1369-77)

  • Induced 3rd-degree burns & severe lung injury in conscious sheep

(J. Zwischenberger et al., “The paracorporeal artificial lung improves 5-Day outcomes from lethal smoke/burn- induced acute respiratory distress syndrome in sheep,” Annals of Thoracic Surgery 74 [2002]: 1011-18)

slide-35
SLIDE 35

European Directive 2010/63/EU: “… the performance of procedures that result in severe pain, suffering or distress [that] is likely to be long-lasting and cannot be ameliorated should be prohibited” (art. 23) Shouldn’t apply only to procedures Ex.: Should prohibit desolate housing conditions that would cause severe long-term suffering

slide-36
SLIDE 36

Standard: Lab animals should not be made to endure severe suffering for any significant length of time We find standard plausible given axiom that sentient animals have moral status We also leave open possibility of extremely rare exceptions

slide-37
SLIDE 37

Beyond the 3 R’s

PART 4

slide-38
SLIDE 38

The 3 R’s framework presented in Russell & Burch’s Principles of Humane Experimental Technique (1959) enjoys nearly unquestioned status in mainstream biomedicine The framework calls for

  • Replacing sentient animals where possible
  • Reducing # of subjects to minimum necessary
  • Refining techniques to minimize pain & distress
slide-39
SLIDE 39

Was a great advance in promoting animal welfare but not adequate today Unlike our approach, the 3 R’s do not:

  • acknowledge that depriving lab animals of basic needs is an

important type of harm

  • limit the amount of permissible harm
  • consider which scientific objectives are worth pursuing—and which

means to pursuing them are justified—in light of social importance, costs or risks to humans & anticipated harms to animals

slide-40
SLIDE 40

A decision tree for evaluating canine studies

PART 5

slide-41
SLIDE 41

Does the proposed use of dogs offer a unique social benefit? NO Don’t use YES Does the proposed use of dogs offer the prospect of net benefit to humanity? NO Don’t use YES Is the prospect of unique net benefit important enough to justify harming the dogs in the ways anticipated? NO Don’t use. YES Does the proposed research avoid unnecessary harm? NO Don’t use. YES Will the dogs’ basic needs be met except where incompatible with scientific objectives? NO Don’t use. YES Will the dogs avoid severe, persisting suffering?

  • NO. Don’t use.

YES

slide-42
SLIDE 42

Final Thoughts

PART 6

slide-43
SLIDE 43

Recent decades have seen growing concern about animal protection The American public today expresses ambivalence about animal research (Ike Swetlitz, “Americans’ opposition to animal testing at record high,” STAT (May 12,

2017; https://www.statnews.com/2017/05/12/americans-oppose-animal-testing/); NAVS, “Gallup poll: More Americans support animal testing” (June 6, 2018; https://www.navs.org/gallup-poll-americans-support-medical-testing-animals/;

  • M. Strauss, “Americans are divided over the use of animals in scientific research” [www.pewresearch.org/fact-

tank/2018/08/16])

slide-44
SLIDE 44

Yet protections of animal subjects—at least in the U.S.— have not evolved much since the 1980s Leaves an opening An adequate framework must reflect honesty about animal research science & competence in animal ethics

slide-45
SLIDE 45

Our framework may be acceptable to

  • proponents of animal research who can accept implications of the

idea that animals have moral status

  • animal protectionists who are willing to consider individual animal

studies, or categories of animal research, on their merits

  • the general public

We hope it shows how socially beneficial involvement of animals in research is compatible with their having decent lives

slide-46
SLIDE 46

Thank you for your kind attention!